Cronos Group Executive and Leadership Team

Héctor Chacón Pérez, the Chief Executive Officer & Founder at Cronos Group, directs the overarching vision for cannabinoid innovation. Establishing the foundational framework for international production, the Chief Executive Officer & Founder aligns research initiatives with global market demands. This leadership role involves navigating complex regulatory landscapes across five continents to ensure consistent product delivery. By fostering partnerships with scientific institutions, Héctor Chacón Pérez accelerates the development of proprietary formulations. The Chief Executive Officer & Founder maintains a focus on long-term value creation through strategic investments in manufacturing infrastructure. Overseeing the expansion of distribution networks, the Chief Executive Officer & Founder ensures that Cronos Group remains at the forefront of the industry. Through disciplined management of corporate resources, the Chief Executive Officer & Founder drives the mission of transforming the global cannabinoid sector while upholding the highest standards of operational excellence and product integrity.

Michael Gorenstein, the Chairman, President & Chief Executive Officer at Cronos Group, architects the strategic roadmap for corporate governance and market expansion. Leading the executive team, the Chairman, President & Chief Executive Officer synchronizes internal business units with the broader mission of scaling cannabinoid production. This role requires constant engagement with the Board to refine capital allocation strategies and enhance shareholder value. Michael Gorenstein manages the integration of new technologies into the supply chain to optimize efficiency across international territories. By prioritizing sustainable growth, the Chairman, President & Chief Executive Officer secures the competitive positioning of Cronos Group within the global marketplace. The Chairman, President & Chief Executive Officer monitors macroeconomic trends to adjust corporate objectives, ensuring agility in a rapidly evolving industry. Through decisive leadership, the Chairman, President & Chief Executive Officer fosters a culture of innovation that supports the delivery of high-quality products to diverse consumer segments worldwide.

Anna Shlimak, the Chief Financial Officer at Cronos Group, manages the fiscal health and capital structure of the organization. Overseeing financial reporting and investor relations, the Chief Financial Officer ensures transparency and accuracy in all monetary disclosures. This role involves analyzing market data to support strategic decision-making regarding international expansion and production capacity. Anna Shlimak directs the budgeting process, allocating resources to high-growth areas within the cannabinoid portfolio. By implementing robust financial controls, the Chief Financial Officer mitigates risks associated with global operations across five continents. The Chief Financial Officer collaborates with other C-suite leaders to evaluate potential acquisitions and partnerships that align with the long-term financial goals of Cronos Group. Through meticulous oversight of cash flow and balance sheet management, the Chief Financial Officer provides the stability necessary for the company to pursue aggressive innovation targets while maintaining a strong financial foundation for future development.

Mike Kroslak, the Chief Operating Officer at Cronos Group, directs the internal scaling of manufacturing processes and supply chain logistics. Focusing on operational efficiency, the Chief Operating Officer optimizes production workflows to meet the demands of international distribution networks. This role involves managing the day-to-day execution of business strategies across diverse geographic regions. Mike Kroslak coordinates with technical teams to ensure that manufacturing facilities adhere to strict quality control protocols. By streamlining logistics, the Chief Operating Officer reduces lead times and enhances the reliability of the product supply chain. The Chief Operating Officer monitors performance metrics to identify bottlenecks and implement process improvements that support the overall growth objectives of Cronos Group. Through effective management of operational assets, the Chief Operating Officer ensures that the company maintains a consistent and scalable output, enabling the successful delivery of cannabinoid products to markets across five continents.

Dinor Levi, the Co-founder & Chief Operating Officer at Cronos Group, architects the operational framework for global product development and facility management. Focusing on the integration of advanced manufacturing technologies, the Co-founder & Chief Operating Officer ensures that production capabilities align with the evolving needs of the cannabinoid industry. This leadership role involves overseeing the implementation of standardized operating procedures across all international sites. Dinor Levi drives initiatives to enhance operational agility, allowing the company to respond rapidly to shifts in market demand. By fostering collaboration between research and production teams, the Co-founder & Chief Operating Officer accelerates the transition from laboratory concepts to commercial-scale manufacturing. The Co-founder & Chief Operating Officer manages the infrastructure requirements necessary to support the global footprint of Cronos Group. Through a commitment to operational excellence, the Co-founder & Chief Operating Officer ensures that the company maintains its competitive edge in the global cannabinoid market.